FDA to Reevaluate Safety of Parkinson ’s Psychosis Drug

Amidst reports of safety concerns involving pimavanserin, a drug approved to treat psychosis symptoms among patients with Parkinson ’s disease, the Food and Drug Administration stated it has begun reassessing the safety of the drug.
Source: Caring for the Ages - Category: Health Management Authors: Source Type: news